Tempest Therapeutics, Inc. (TPST) P/E Ratio, ROE & Key Statistics
$0.33NASDAQ: TPSTMarket Cap $6.54M
Data as of Nov 17, 2026 close · Source: Financial Modeling Prep (methodology)
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Tempest Therapeutics, Inc. (TPST), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-0.10
P/B ratioShare price divided by book value per share.
-3.53
P/S ratioMarket value divided by annual revenue.
0.00
PEG ratioP/E divided by the earnings growth rate.
0.00
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-0.35
EV / RevenueEnterprise value against annual revenue.
0.00
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-1000.00%
Free cash flow yieldFree cash flow as a percentage of market value.
-282.19%
Price / free cash flowMarket value divided by free cash flow.
-0.35
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
0.00%
Operating marginRevenue left after operating costs.
0.00%
Net marginRevenue left after every cost, including tax and interest.
0.00%
Return on equityProfit as a percentage of shareholders’ equity.
-371.43%
Return on assetsProfit as a percentage of total assets.
-463.30%
Return on capital employedOperating profit against the capital the business uses.
-974.32%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
0.34
Quick ratioThe same, excluding inventory.
0.34
Cash ratioCash alone against current liabilities.
2.67
Debt to equityTotal borrowings against shareholders’ equity.
-3.97
Debt to assetsTotal borrowings against total assets.
0.47
Interest coverageHow many times operating profit covers the interest bill.
-48.09
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
−$6.33
Book value per shareShareholders’ equity divided by shares outstanding.
−$0.11
Market capitalisationShare price times shares outstanding.
$6.54M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$13.64M
EmployeesReported headcount.
24
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Tempest Therapeutics, Inc. (TPST) statistics — frequently asked questions
What is Tempest Therapeutics, Inc.'s P/E ratio?
Tempest Therapeutics, Inc. (TPST) trades on a price-to-earnings ratio of -0.10. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Tempest Therapeutics, Inc.'s return on equity?
Tempest Therapeutics, Inc. (TPST) reports a return on equity of -371.43%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Tempest Therapeutics, Inc. carry?
Tempest Therapeutics, Inc. (TPST) has a debt-to-equity ratio of -3.97, which compares total borrowings with shareholders' equity.